++
Neurodevelopmental impairment in infants born preterm.
+++
GUIDELINE OBJECTIVE(S)
++
To review the frequency and impact (medical, social, and economic) of and contributors to long-term neurodevelopmental impairment in preterm infants. To discuss methods to predict and improve neurodevelopmental outcomes in these infants. Outcomes in term infants are not addressed in this chapter.
+++
Prevalence of Neurodevelopmental Impairment
++
The improved survival rates for preterm infants over the past several decades have not translated into improvements in long-term neurodevelopmental outcomes. Preterm birth remains a leading cause of neurological and neurodevelopmental disabilities worldwide. In the United States alone, the medical costs associated with preterm birth amount to $17 billion per year, with combined costs of medical and social services amounting to more than $26 billion.
+++
Very Preterm Infants (Born <32 Weeks’ Gestation)
++
Infants born at the earliest gestational ages experience the greatest rates of adverse neurodevelopmental sequelae. Impairments include cognitive, language, motor, social, and behavioral disability, with 30–50% of very preterm (VPT) children experiencing impairments across multiple developmental domains. Approximately 10% of VPT infants experience severe deficits associated with functional disability, including cerebral palsy (CP), intellectual disability (IQ <70), and/or severe visual or hearing impairments. Many deficits are identifiable by 2 years of age. Mild to moderate deficits are seen in an additional 30–50% of VPT infants, with some impairments not evident until school age. Table 58.1 provides a summary of the literature regarding the prevalence of neurodevelopmental challenges for VPT infants.
++